We identified CD36, MMP1, TGFBR3, TWIST2, ITGB1, and FGF19 as associated with poorer outcomes: CD36 enhances tumour stemness and growth [182], MMP1 facilitates metastasis [183], TGFBR3 and TWIST2 promote EMT and invasion [184], ITGB1 supports cell adhesion and survival [185], and FGF19 drives proliferation [142]. The gene discussed is TWIST2; the disease is neoplasm.